BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7796420)

  • 1. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
    el-Deiry WS; Tokino T; Waldman T; Oliner JD; Velculescu VE; Burrell M; Hill DE; Healy E; Rees JL; Hamilton SR
    Cancer Res; 1995 Jul; 55(13):2910-9. PubMed ID: 7796420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues.
    Fredersdorf S; Milne AW; Hall PA; Lu X
    Am J Pathol; 1996 Mar; 148(3):825-35. PubMed ID: 8774137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
    Zupanska A; Adach A; Dziembowska M; Kaminska B
    Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
    Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
    J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 gene mediated by cis elements present in the 3'-untranslated region.
    Rishi AK; Hsu CK; Li XS; Hussain A; Gerald TM; Fontana JA
    Cancer Res; 1997 Nov; 57(22):5129-36. PubMed ID: 9371514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
    Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
    Saied IT; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
    Liu Y; Martindale JL; Gorospe M; Holbrook NJ
    Cancer Res; 1996 Jan; 56(1):31-5. PubMed ID: 8548769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
    Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
    Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells.
    Li XS; Rishi AK; Shao ZM; Dawson MI; Jong L; Shroot B; Reichert U; Ordonez J; Fontana JA
    Cancer Res; 1996 Nov; 56(21):5055-62. PubMed ID: 8895764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression.
    Liu M; Pelling JC
    Oncogene; 1995 May; 10(10):1955-60. PubMed ID: 7761096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Messenger RNA expression of p21WAF1/CIP1 in colorectal carcinoma tissues].
    Kobayashi S; Matsushita K; Isono K
    Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):457-62. PubMed ID: 9742528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U; Durka S; Weller M
    Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
    Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
    Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx.
    Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A
    J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
    Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.